AIG
PNT

American International Group’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

American International Group’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-45,158
Closed -$301K – 3046
2023
Q3 		$301K Buy
45,158
+1,605
+4% +$13.3K ﹤0.01% 1888
2023
Q2 		$395K Buy
43,553
+1,655
+4% +$14.6K ﹤0.01% 1793
2023
Q1 		$305K Buy
41,898
+1,464
+4% +$10.9K ﹤0.01% 1875
2022
Q4 		$295K Buy
40,434
+5,276
+15% +$39.2K ﹤0.01% 1903
2022
Q3 		$272K Buy
35,158
+497
+1% +$4.22K ﹤0.01% 1977
2022
Q2 		$236K Buy
+34,661
New +$265K ﹤0.01% 2083

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

American International Group's PNT Position: Q4 2023 in Review

American International Group sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 45,158 shares — an estimated $301K sold.

American International Group first reported a position in PNT in Q2 2022 and held it in 6 quarters. The position peaked at $395K in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • American International Group reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • American International Group sold 45,158 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $301K.
  • American International Group first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2022 and held it in 6 quarters.
  • American International Group's POINT Biopharma Global Inc. Common Stock position peaked at $395K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on American International Group's 13F filing for Q4 2023, filed 13 Feb 2024.